| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | -4.819 | -230 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | -2.524 | -230 | 0 | 0 | 0 | 0 | 1.333 | 0 | 0 | 0 |
| Total Expenses - EUR | 7.182 | 171 | 0 | 0 | 1.055 | 0 | 18.856 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -9.706 | -402 | 0 | 0 | -1.055 | 0 | -17.522 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -9.706 | -402 | 0 | 0 | -1.055 | 0 | -17.562 | 0 | 0 | 0 |
| Employees | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Radical Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 77.760 | 69.038 | 67.870 | 66.569 | 21.057 | 20.658 | 78 | 119 | 118 | 118 |
| Inventories | 59.520 | 58.913 | 57.916 | 56.853 | 11.568 | 11.348 | 0 | 0 | 0 | 0 |
| Receivables | 18.102 | 10.081 | 9.911 | 9.673 | 9.486 | 9.306 | 78 | 119 | 118 | 118 |
| Cash | 138 | 44 | 44 | 43 | 4 | 4 | 0 | 0 | 0 | 0 |
| Shareholders Funds | 21.165 | 20.547 | 20.199 | 19.829 | 18.389 | 18.041 | 78 | 78 | 78 | 78 |
| Social Capital | 1.350 | 1.336 | 1.313 | 1.289 | 1.264 | 1.240 | 1.213 | 1.217 | 1.213 | 1.206 |
| Debts | 56.595 | 48.491 | 47.671 | 46.740 | 2.667 | 2.617 | 0 | 40 | 40 | 40 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Radical Pharma Srl